Cargando…
SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients
BACKGROUND: In hemodialysis patients, a third vaccination is frequently administered to augment protection against coronavirus disease 2019 (COVID-19). However, the newly emerged B.1.1.159 (Omicron) variant may evade vaccinal protection more easily than previous strains. It is of clinical interest t...
Autores principales: | Wang, Xiaoling, Han, Maggie, Fuentes, Lemuel Rivera, Thwin, Ohnmar, Grobe, Nadja, Wang, Kevin, Wang, Yuedong, Kotanko, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470295/ https://www.ncbi.nlm.nih.gov/pubmed/36106337 http://dx.doi.org/10.3389/fneph.2022.926635 |
Ejemplares similares
-
Testing of worn face mask and saliva for SARS-CoV-2
por: Wang, Xiaoling, et al.
Publicado: (2023) -
SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population
por: Thwin, Ohnmar, et al.
Publicado: (2021) -
Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data
por: Duan, Juntao, et al.
Publicado: (2023) -
Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies
por: Wang, Lin-Chun, et al.
Publicado: (2021) -
Sodium First Approach, to Reset Our Mind for Improving Management of Sodium, Water, Volume and Pressure in Hemodialysis Patients, and to Reduce Cardiovascular Burden and Improve Outcomes
por: Canaud, Bernard, et al.
Publicado: (2022)